Smith & Nephew pays $1.7bn to acquire sports medicine company ArthroCare
Smith & Nephew PLC has strengthened its surgical resection and sports medicine businesses through the acquisition of minimally invasive surgical device company ArthroCare Corp., paying $48.25 per share in cash, a slight premium to ArthroCare’s pre-announcement closing average, for a total consideration of $1.7bn--more than four and a half times the company’s 2012 sales.
- Medical Devices
- Implantable Devices
- Radiofrequency Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.